News and Comments

ILMN AND HGSI: REASONS FOR ATYPICAL REJECTIONS OF TAKEOVERS

  Sunday, April 22, 2012

These days all the focus, the talk, the debates, and the confusion are, and will certainly continue for a while to be, about Illumina’s (ILMN) and Human Genome’s (HGSI) rejection of the acquisitions offers. The truth is that the offers were not as generous as they are said they are. More...

AFFYMAX vs. AMGEN?

  Tuesday, April 03, 2012

Affymax (AFFY) red blood growth factor drug Omontys (peginesatide) was granted FDA approval – good news for the firm. The approval is a remarkable achievement by Affymax. The firm has proven a capability developing biological products and there is no doubt that AFFY will sell the drug Omontys for patients with chronic kidney disease on dialysis, as it is dictated by the FDA.  More...


Recent Postings


Archive


Tags

Roche (ROCHE) KITE (KITE) Prosensa (RNA) NEKTAR (NKTR)) GlaxoSmithKline (GSK) ISIS (ISIS) Prolor Biotech (PBTH) Pluristem (PSTI) Seattle Genetics (SGEN) Sanofi (SNA) AERIE PHARMACEUTICALS Herceptin OSI (OSIP) Onyx (ONXX) IDERA (IDRA) Sangamo (SGMO) Intercept (ICPT) Human Genome Sciences (HGSI) Roche (RHHBY) Auspex (ASPX) Tysabri Genentech Rapamune Xoma (XOMA) Elan (ELN) Dendreon (DNDN) ZALTRAP™ Benlysta (belimumab) Bristol-Myers Squibb (BMY) TOKAI (TKAOI) Exelixis (EXEL) Merck (MRK) Theravance (THRX) Amgen (AMGN) Alnylam (ALNY) Aimmune Therapeutics (AIMT) Gilead (GILD) Ariad (ARIA) Velcade (bortezomib) Agenus (AGEN) Inovio (INO) Illumina (ILMN) Sarepta (SRPT) JUNO (JUNO) Cytokinetics (CYTK) Trastuzumab-DM1 BIOMARIN (BMRN) Sanofi-Aventis (SAN) Galena (GALE) ImmunoGen (IMGN) Array Pharmaceuticals (ARRY) ADVENTRIX (ANX) Endometrial Cancer GUARDIAN HEALTH HALOZYME (HALO) Sequenom (SQNM) Telaprevir Regeneron (REGN) Sanofi (SNY) Dynavax (DVAX) SUNESIS PHARMACEUTICALS (SNSS) VANDA (VNDA) galapagos (GLPG) Intermune (ITMN) Biocryst (BCRX) Biogen Idec (BIIB) ARCA (ABIO) Incyte (INCY) SERES THERAPEUTICS (MCRB) Ridaforolimus Revlimid (lenolidamide) KERYX (KERX) Idenix (IDIX) Mirati Therapeutics (MRTX) Anacor (ANAC) CompuGen (CGEN) Zerenex Ziofpharm (ZIOP) Anadys (ANDS) Agenus (AGEN Micromet (MITI) Multiple Myeloma ABBVIE (ABBV) Jazz Pharmaceuticals (JAZZ) NANTKWEST (NK) C4 Therapeutics Valeant Pharmaceuticals International (VRX) SYNTA (SNTA) Vertex (VRTX) Abbott Laboratories (ABT) Intrexon (XON)